Underlying factors in the willingness to receive and barriers to receiving the COVID-19 vaccine among residents in the UK and Nigeria: a qualitative study.

Abstract

Qualitative data on the factors underlying the willingness to receive and barriers to receiving the COVID-19 vaccine were scant in the literature. Therefore, the authors employed a qualitative design with a heterogeneous sample of 60 residents (age range = 18-79 years) in the UK and Nigeria to explore the factors underlying their willingness to receive and barriers to receiving the COVID-19 vaccine. The thematic analysis was employed to analyze data. The results revealed that only a small number of the participants had received the COVID-19 vaccine; they experienced soreness and itchiness, and their motive for receiving the vaccine was its availability. The participants who had not received the vaccine reported the following as determinants of their willingness to receive the vaccine: “concerns about the side/adverse effect”, “the perceived benefit of receiving the vaccine”, “mistrust (in the pharmaceutical companies that produced the vaccine, the vaccine itself, or governments)”, “the need for clarity of information on the vaccine”, and “moral obligation to receive the vaccine”. The participants who had not received the vaccine further reported the following as other barriers that limit them from receiving the vaccine: “unavailability of the vaccine in the country of residence”, “non-membership to a high-risk group”, and “membership to a minority group”. In terms of what governments can do to encourage public uptake of the vaccine, many participants reported: “provide clear information on the COVID-19 vaccine”, “endorsement by public figures”, “make the vaccine free to receive”, “introduce rewards and punishments”, and “honesty from governments”. Implications for practice are highlighted.